%0 Journal Article
%T Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors
%A Jyoti Malhotra
%A Salma K. Jabbour
%A Sharon Pine
%J SCIE-indexed Journal
%D 2019
%R 10.21037/tlcr.2019.05.04
%X Lung cancer is the second most common cancer in both men and women and non-small cell lung cancer (NSCLC) accounts for more than 86% of all lung cancers (1). Lung cancer survivors are a growing yet understudied patient population. Even with the high mortality associated with lung cancer, the number of lung cancer patients added to the survivor population every year is significantly high due to high lung cancer incidence rates (224,210 new cases diagnosed annually) (1). Approximately 26,000 individuals become long-term lung cancer survivors annually (2). There are approximately 526,510 lung cancer survivors in the US as of January 2016, and this number is expected to rise to 673,370 by 2026 (1). Beyond this estimate, the number of survivors will likely increase further with the implementation of lung cancer screening in smokers that can detect patients with early-stage (stage I and II) NSCLC. The majority of the lung cancer survivors are patients with early-stage NSCLC who are treated with surgery. These patients have a significant risk of mortality as the 5-year survival for early-stage NSCLC is only 55.6% (3). These poor survival rates are primarily because lung cancer survivors have a significantly higher risk for developing another lung cancer; either a new cancer (1¨C2% per-year risk) or recurrent disease (10¨C38% overall risk) (4,5). They are also at higher risk for other cancers such as cancers of the larynx, colon, esophagus and stomach with the estimated risk being 3¨C6% per year (6)
%U http://tlcr.amegroups.com/article/view/28899/23674